-
EP1800684
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1800684
| EP1800684 - Novel alkyl phospholipid derivatives and uses thereof [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.06.2008 Database last updated on 19.10.2024 | Most recent event Tooltip | 13.06.2008 | Application deemed to be withdrawn | published on 16.07.2008 [2008/29] | Applicant(s) | For all designated states Æterna Zentaris GmbH Weismüllerstrasse 50 60314 Frankfurt am Main / DE | [N/P] |
| Former [2007/34] | For all designated states AEterna Zentaris GmbH Weismüllerstrasse 50 60314 Frankfurt / DE | ||
| Former [2007/26] | For all designated states Zentaris GmbH Weismüllerstrasse 50 60314 Frankfurt/Main / DE | Inventor(s) | 01 /
Perrissoud, Daniel Wilhelm-Meister-Str. 7 61348 Bad Homburg / DE | 02 /
Pietras, Mathias Am Sonnenberg 3 61279 Grävenwiesbach / DE | 03 /
Engel, Jürgen, Prof. Dr. Erlenweg 3 63755 Alzenau / DE | [2007/26] | Application number, filing date | 05027823.3 | 20.12.2005 | [2007/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1800684 | Date: | 27.06.2007 | Language: | EN | [2007/26] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 22.06.2006 | Classification | IPC: | A61K31/661, A61K31/675, A61K31/683, A61K31/685, A61P31/00, A61P31/04, A61P31/06, A61P31/08, A61P31/10, A61P31/12, A61P31/14, A61P31/16, A61P31/18, A61P31/20, A61P31/22, A61P33/00, A61P33/02, A61P33/04, A61P33/06, A61P33/08, A61P33/12, A61P35/00 | [2007/26] | CPC: |
A61K31/675 (EP);
A61K31/661 (EP);
A61K31/683 (EP);
A61K31/685 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/06 (EP);
A61P31/08 (EP);
A61P31/10 (EP);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/16 (EP);
A61P31/18 (EP);
A61P31/20 (EP);
A61P31/22 (EP);
A61P33/00 (EP);
A61P33/02 (EP);
A61P33/04 (EP);
A61P33/06 (EP);
A61P33/08 (EP);
A61P33/12 (EP);
| Designated contracting states | (deleted) [2008/10] |
| Former [2007/26] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Neue Alkylphospholipidderivate und deren Verwendung | [2007/26] | English: | Novel alkyl phospholipid derivatives and uses thereof | [2007/26] | French: | Nouveaux alkylphospholipides et leur utilisation | [2007/26] | Examination procedure | 28.12.2007 | Application deemed to be withdrawn, date of legal effect [2008/29] | 19.02.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2008/29] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.12.2007 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP0284395 (NIPPON CHEMIPHAR CO [JP]) [A] 17,18* the whole document *; | [X]EP0579939 (ASTA MEDICA AG [DE]) [X] 1,2,5,6,8,13,14,16,18 * the whole document *; | [A]WO0033917 (MAX DELBRUECK CENTRUM [DE], et al) [A] 17,18 * abstract *; | [X]US2003216355 (ENGEL JURGEN [DE]) [X] 1,2,5,8,16,18,19 * paragraphs [0002] , [0026]; claims 1-17 *; | [X]US2004242543 (ENGEL JURGEN [DE]) [X] 1,2,5,8,16,18,19 * abstract * * paragraphs [0002] , [0026]; claims 1-18 *; | [X] - VERMA NAVIN K ET AL, "Possible mechanism of miltefosine-mediated death of Leishmania donovani.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. AUG 2004, (200408), vol. 48, no. 8, ISSN 0066-4804, pages 3010 - 3015, XP002372749 [X] 1 * the whole document * DOI: http://dx.doi.org/10.1128/AAC.48.8.3010-3015.2004 | [X] - WALOCHNIK JULIA ET AL, "Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. MAR 2002, (200203), vol. 46, no. 3, ISSN 0066-4804, pages 695 - 701, XP001146164 [X] 1 * the whole document * DOI: http://dx.doi.org/10.1128/AAC.46.3.695-701.2002 | [X] - SUNDAR S ET AL, "Trial of oral miltefosine for visceral leishmaniasis", LANCET, (19981205), vol. 352, no. 9143, ISSN 0140-6736, pages 1821 - 1823, XP004835202 [X] 1 * the whole document * DOI: http://dx.doi.org/10.1016/S0140-6736(98)04367-0 | [X] - KOUFAKI M ET AL, "Alkyl and alkoxyethyl antineoplastic phospholipids.", JOURNAL OF MEDICINAL CHEMISTRY. 21 JUN 1996, (19960621), vol. 39, no. 13, ISSN 0022-2623, pages 2609 - 2614, XP002372751 [X] 1 * the whole document * DOI: http://dx.doi.org/10.1021/jm9509152 | [A] - KONSTANTINOV, SPIRO M. ET AL, "Alkylphosphocholines induce apoptosis in HL-60 and U-937 leukemic cells", CANCER CHEMOTHERAPY AND PHARMACOLOGY , 41(3), 210-216 CODEN: CCPHDZ; ISSN: 0344-5704, (1998), XP008061677 [A] 17,18 * the whole document * DOI: http://dx.doi.org/10.1007/s002800050730 | [A] - ENGEL, J. ET AL, "Perifosine: oncolytic, ether phospholipid", DRUGS OF THE FUTURE , 25(12), 1257-1260 CODEN: DRFUD4; ISSN: 0377-8282, (2000), XP008061690 [A] 17,18 * the whole document * DOI: http://dx.doi.org/10.1358/dof.2000.025.12.604732 |